EVH logo
Evolent Health, Inc.(EVH)
Last print unknown agoAbout this dataData status
$4.48▼-0.09 (-1.97%)Stale · unknown old

EVH R&D Expense Growth

0.00%Fiscal year

Period ending:

EVH FY R&D Growth (YoY)%
EVH FY R&D Growth (YoY)114.34%-122.97%
2012-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year. Growth compares with the corresponding period one year earlier.

EVH r&d expense growth history

Year-over-year research & development expense growth. The available annual fiscal periods series contains 14 observations from Dec 31, 2012 to Dec 31, 2025.

Evolent Health Inc Class A R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
0%
0%
-100%
0%
0%
0%
-100%
5.814%
54.955%
91.3793%
0%
-100%
0%
0%

Compare r&d expense growth

All EVH financial metrics · EVH stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.